Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-11-24

Clinical Trial Update: Lignin in Treatment of Helicobacter Pylori Infection [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating lignin for treating Helicobacter pylori infection; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lignin (lignin)

Snippet

Sponsor: Zagazig University | Conditions: HELICOBACTER PYLORI INFECTIONS | Phase 3 | Status: ACTIVE_NOT_RECRUITING